apilimod: Clinical Trials

3 trials of apilimod, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow apilimod: new trials by email Literature Review of apilimod trials Research Report on apilimod

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma
LAM-002A, Rituximab, Atezolizumab - Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic
Phase 1CompletedIRulya Therapeutics Inc.622015-10-012024-08-22
STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency
STA-5326 - Common Variable Immunodeficiency
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)102005-12-022017-07-02
STA-5326 in Crohn's Disease Patients
STA-5326 - Crohn's Disease
Phase 1 / Phase 2CompletedSynta Pharmaceuticals Corp.482004-02-012005-06-24

Conditions studied

Common Variable Immunodeficiency (1)  ·  Crohn Disease (1)  ·  Leukemia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Malabsorption Syndromes (1)

Sponsors

IRulya Therapeutics Inc. (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Synta Pharmaceuticals Corp. (1)

Countries

United States (3)

Top investigators

Langdon Miller, MD (1)